Delivery Order SPE2DB22D9316-SPE2DB25FYN13

Award Date 1/23/25
Potential Completion Date 2/13/25
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,734.96, is for the delivery of NEXPLANON 68 MG IMPLANTS to the DLA. This order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NEXPLANON 68 MG IMPLANTS, with a ceiling value of $6,837.40 and a period of performance through May 8, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and DLA, valued at up to $499,999,999, which allows the DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $42,881.40, is for the supply of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
The Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $3,573.45 to DMS Pharmaceutical Group Inc., a woman-owned small business, for the provision of NEXPLANON 68 MG IMPLANTS. This award has no set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler based in Park Ridge, Illinois that offers a comprehensive range of brand and generic pharmaceutical products and medical supplies to U.S. government agencies, including the...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $25,728.84 firm fixed-price contract is for the delivery of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which enables...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $21,440.70, is for the procurement of NEXPLANON 68 MG IMPLANTS with a completion date of September 25, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under...
The Defense Logistics Agency (DLA) awarded a $3,573.45 firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Nexplanon 68 mg implants. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through December 31, 2025. The IDC allows the DLA to issue...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,299.20 contract is for the delivery of NEXPLANON 68 MG IMPLANTS to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program that allows for the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,858.76, is for the delivery of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which covers...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $5,717.52, is for the procurement of NEXPLANON 68 MG IMPLANTS. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc. under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB25FYN13
    Delivery Order

This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,886.20, is for the provision of NEXPLANON 68 MG IMPLANTS to support the medical supply needs of military healthcare facilities. The award is not associated with any set-aside designation.

DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain.

Generated 4/24/25, 10:42 AM